- Home
- AQST vs TALK Comparison
AQST vs TALK Comparison
Compare AQST & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- TALK
- Stock Information
- Founded
- AQST 2004
- TALK 2012
- Country
- AQST United States
- TALK United States
- Employees
- AQST N/A
- TALK N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- TALK Medical/Nursing Services
- Sector
- AQST Health Care
- TALK Health Care
- Exchange
- AQST Nasdaq
- TALK Nasdaq
- Market Cap
- AQST 272.9M
- TALK 476.8M
- IPO Year
- AQST 2018
- TALK N/A
- Fundamental
- Price
- AQST $3.72
- TALK $2.79
- Analyst Decision
- AQST Strong Buy
- TALK Buy
- Analyst Count
- AQST 6
- TALK 6
- Target Price
- AQST $10.67
- TALK $4.50
- AVG Volume (30 Days)
- AQST 1.5M
- TALK 1.8M
- Earning Date
- AQST 08-05-2025
- TALK 08-05-2025
- Dividend Yield
- AQST N/A
- TALK N/A
- EPS Growth
- AQST N/A
- TALK N/A
- EPS
- AQST N/A
- TALK 0.02
- Revenue
- AQST $54,228,000.00
- TALK $194,359,000.00
- Revenue This Year
- AQST N/A
- TALK $22.39
- Revenue Next Year
- AQST $45.71
- TALK $20.33
- P/E Ratio
- AQST N/A
- TALK $159.53
- Revenue Growth
- AQST 5.29
- TALK 19.88
- 52 Week Low
- AQST $2.12
- TALK $1.60
- 52 Week High
- AQST $5.80
- TALK $4.36
- Technical
- Relative Strength Index (RSI)
- AQST 68.53
- TALK 41.17
- Support Level
- AQST $3.13
- TALK $2.62
- Resistance Level
- AQST $3.33
- TALK $2.83
- Average True Range (ATR)
- AQST 0.22
- TALK 0.12
- MACD
- AQST 0.01
- TALK -0.02
- Stochastic Oscillator
- AQST 94.17
- TALK 21.86
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.